B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Ciforadenant

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Ciforadenant, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

rolofylline
4 shared targets
istradefylline
4 shared targets
st1535
3 shared targets
zm
4 shared targets
ib
4 shared targets
cgs
3 shared targets
r
3 shared targets
regadenoson
3 shared targets
metrifudil
3 shared targets
tecadenoson
3 shared targets
Loading evidence profile...

This evidence profile for Ciforadenant is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.